These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10623223)

  • 1. Making a recovery. With premiums rising and medical costs under control, HMOs are looking a lot healthier.
    Rauber C
    Mod Healthc; 1999 Oct; 29(41):50. PubMed ID: 10623223
    [No Abstract]   [Full Text] [Related]  

  • 2. HMOs' stock debacle changes the game.
    Johnson DE
    Health Care Strateg Manage; 1996 Aug; 14(8):2-3. PubMed ID: 10159391
    [No Abstract]   [Full Text] [Related]  

  • 3. Stock market successes and HMO growing pains.
    Gemignani J
    Bus Health; 1998 Apr; 16(4):35-6, 38-9. PubMed ID: 10178400
    [No Abstract]   [Full Text] [Related]  

  • 4. Initial public offerings slow as HMOs fail to extract substantial profits.
    Graham J
    Mod Healthc; 1986 Jun; 16(13):62. PubMed ID: 10276957
    [No Abstract]   [Full Text] [Related]  

  • 5. Healthcare stocks: some bright spots in a cloudy year.
    Nemes J
    Mod Healthc; 1993 Feb; 23(5):47. PubMed ID: 10123709
    [No Abstract]   [Full Text] [Related]  

  • 6. Investor-owned HMOs' enrollments up; first-quarter net income results mixed.
    Richman D
    Mod Healthc; 1986 Jun; 16(13):30. PubMed ID: 10276950
    [No Abstract]   [Full Text] [Related]  

  • 7. Public ownership helps boost HMOs' profits.
    Kenkel PJ
    Mod Healthc; 1992 May; 22(18):34. PubMed ID: 10117606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earnings at a premium. Rate increases fuel gains for HMOs hit by rising costs, faltering economy.
    Benko LB
    Mod Healthc; 2002 Feb; 32(6):22-3. PubMed ID: 11892530
    [No Abstract]   [Full Text] [Related]  

  • 9. Fortune 500 medians.
    Fortune; 1997 Apr; 135(8):F24-6. PubMed ID: 10166666
    [No Abstract]   [Full Text] [Related]  

  • 10. Fortune 500 ranked within states.
    Fortune; 1997 Apr; 135(8):F32-43. PubMed ID: 10166668
    [No Abstract]   [Full Text] [Related]  

  • 11. HMO stocks up.
    Kenkel PJ
    Mod Healthc; 1989 Feb; 19(7):4. PubMed ID: 10291925
    [No Abstract]   [Full Text] [Related]  

  • 12. Fortune 500 ranked by performance.
    Fortune; 1997 Apr; 135(8):F27-31. PubMed ID: 10166667
    [No Abstract]   [Full Text] [Related]  

  • 13. Fortune 500 largest U.S. corporations.
    Fortune; 1997 Apr; 135(8):F1-23. PubMed ID: 10166665
    [No Abstract]   [Full Text] [Related]  

  • 14. Market deflates for provider-owned HMOs. Survey shows many plans are losing ground to growing national and regional players.
    Rauber C
    Mod Healthc; 1999 Jun; 29(24):34-8, 40-4, 46. PubMed ID: 10538574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profitability of HMOs: does non-profit status make a difference?
    Bryce HJ
    Health Policy; 1994 Jun; 28(3):197-210. PubMed ID: 10135877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How two for-profit HMOs manage expenditures.
    Sherlock D
    Healthspan; 1985; 2(8):11-5. PubMed ID: 10273833
    [No Abstract]   [Full Text] [Related]  

  • 17. Big changes at Oxford. Rosier outlook gives troubled HMO maneuvering room.
    Rauber C
    Mod Healthc; 1998 Oct; 28(41):50. PubMed ID: 10185618
    [No Abstract]   [Full Text] [Related]  

  • 18. Survey search: What makes HMOs run?
    Health Cost Manage; 1986; 3(5):32-5. PubMed ID: 10279244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-control burden on HMOs' shoulders.
    Kertesz L
    Mod Healthc; 1998 Mar; 28(11):78, 80. PubMed ID: 10178267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMO stock options good for hospitals?
    Johnson DE
    Health Care Strateg Manage; 1994 Mar; 12(3):2-3, 11. PubMed ID: 10132499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.